FIELD: chemistry.
SUBSTANCE: invention relates to novel derivatives of formula I, as well as to pharmaceutical compositions based thereon
.
EFFECT: technical result is obtaining new compounds having agonistic activity on glucocorticoid or mineralocorticoid receptors, which can be used for treating disorders associated with modulation of glucocorticoid or mineralocorticoid receptor, for example, dry eyes.
10 cl, 3 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS AND METHODS FOR APPLICATION OF 4-PREGNEN-11β-17-21-TRIOL-3,20-DIONE DERIVATIVES | 2012 |
|
RU2683775C2 |
| TREATMENT OF HEPATIC ADIPOSITIS WITH APPLICATION OF GLUCOCORTICOID AND MINERALOCORTICOID RECEPTOR ANTAGONISTS | 2015 |
|
RU2718921C2 |
| SELF-EMULSING DRUG DELIVERY SYSTEMS (SEDDS) FOR OPHTHALMIC MEDICINE DELIVERY | 2016 |
|
RU2746083C2 |
| PYRIMIDINECYCLOHEXYL GLUCOCORTICOID RECEPTOR MODIFIERS | 2012 |
|
RU2599253C2 |
| TRICYCLIC LACTAM DERIVATIVES AS 11-β-HYDROXYSTEROID DEHYDROGENASE INHIBITORS | 2005 |
|
RU2386617C2 |
| CYCLIC PURINE DINUCLEOTIDES AS MODULATORS OF STING | 2016 |
|
RU2722019C2 |
| ARYL UREA DERIVATIVES AS N-FORMILEPEPTIDE-1 RECEPTOR (FPRL-1) MODULATORS | 2012 |
|
RU2627271C2 |
| DERIVATIVES OF N-UREA-SUBSTITUTED AMINOACIDS AS MODULATORS OF FORMYL-PEPTIDE RECEPTOR | 2014 |
|
RU2696581C2 |
| AGONIST OF THE GLUCOCORTICOID RECEPTOR AND ITS IMMUNOCONJUGATES | 2017 |
|
RU2745748C2 |
| NONSTEROID COMPOUNDS EFFECTIVE AS GLUCOCORTICOID RECEPTOR MODULATORS | 2006 |
|
RU2420528C2 |
